Kannalife
Biotechnology, Health Care, Pharmaceutical
Founded in 8/10/10
Doylestown, Pennsylvania, United States
For Profit
About Kannalife
Kannalife, a subsidiary of Neuropathix, Inc (OTCQB: NPTX), is a biopharmaceutical company focused on discovering, developing, and commercializing a product platform of novel molecules from our proprietary next-generation cannabinoid therapeutics as potent, non-opioid alternatives to treat patients with a variety of unmet medical needs.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: 19 active products
Financial Information
- Estimated Revenue: Less than $1M
- Total Funding: 4470000 USD
- Last Funding: 2970000 USD (Grant)
- Funding Status:
Technology Stack
Kannalife actively uses 19 products in their tech stack.
Market Presence
Industries: Biotechnology, Health Care, Pharmaceutical
Headquarters: Doylestown, Pennsylvania, United States
Leadership
- Mark Corrao - CFO LinkedIn